EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86 USD | -0.12% |
|
-1.49% | +12.92% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 114 M€ | +3.49% | - | |
| 0.01% | 163 M€ | +0.51% | - | |
| 0.01% | 32 M€ | +3.91% | - | |
| 5.02% | 132 M€ | +9.06% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.1
USD
Average target price
96.31
USD
Spread / Average Target
+11.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.92% | 51.88B | |
| +8.81% | 222B | |
| +23.48% | 148B | |
| +33.51% | 114B | |
| +4.64% | 65.69B | |
| +3.16% | 50.02B | |
| -4.52% | 38.81B | |
| -3.41% | 34.59B | |
| +22.46% | 31.09B | |
| +19.58% | 24.62B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
